| Entry |
|
|---|
| Name |
Fenoldopam (INN);
Carlacor (TN) |
|---|
| Formula |
C16H16ClNO3
|
|---|
| Exact mass |
305.0819
|
|---|
| Mol weight |
305.7561
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
|
|---|
| Remark |
| Product (DG00226): | D00613<US> |
|
|---|
| Efficacy |
Antihypertensive, Diuretic, Dopamine D1 receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA19 Fenoldopam
D07946 Fenoldopam (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
DG00226 Fenoldopam
D07946 Fenoldopam
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D07946 Fenoldopam (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
DG00226 Fenoldopam
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 C1x C 25.3400 -21.9100
2 C8y C 24.5000 -20.7900
3 C8y C 24.8500 -19.4600
4 C1y C 26.1100 -18.9000
5 C1x C 26.7400 -21.9100
6 C1x C 27.3700 -19.5300
7 N1x N 27.6500 -20.8600
8 C8x C 23.8000 -18.4800
9 C8y C 22.4000 -18.9000
10 C8y C 22.0500 -20.2300
11 C8y C 23.1700 -21.2100
12 O1a O 20.7200 -20.6500
13 O1a O 21.4200 -17.9200
14 X Cl 22.8200 -22.6100
15 C8y C 26.1100 -17.5000
16 C8x C 27.3000 -16.8000
17 C8x C 27.3000 -15.4000
18 C8y C 26.1100 -14.7000
19 C8x C 24.8500 -15.4000
20 C8x C 24.8500 -16.8000
21 O1a O 26.1100 -13.3000
BOND 23
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 10 12 1
14 9 13 1
15 11 14 1
16 4 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
|
|---|
